Audrey Claing, Ph.D
Affiliations: | Pharmacologie | Université de Montréal, Montréal, Canada |
Area:
GPCRsWebsite:
http://www.pharmacologie.umontreal.ca/professeurs_chercheurs/claing/index.htmlGoogle:
"Audrey Claing"Mean distance: 21373.2
Children
Sign in to add trainee| Mathieu Cotton | grad student | 2006 | Université de Montréal |
| Pierre-Luc Boulay | grad student | 2011 | Université de Montréal |
| Derek N. Robertson | post-doc | 2006-2008 | Université de Montréal |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Giubilaro J, Schuetz DA, Stepniewski TM, et al. (2021) Discovery of a dual Ras and ARF6 inhibitor from a GPCR endocytosis screen. Nature Communications. 12: 4688 |
| Charles R, Bourmoum M, Campbell S, et al. (2019) Methods to Investigate the β-Arrestin-Mediated Control of ARF6 Activation to Regulate Trafficking and Actin Cytoskeleton Remodeling. Methods in Molecular Biology (Clifton, N.J.). 1957: 159-168 |
| Charles R, Bourmoum M, Claing A. (2018) ARF GTPases control phenotypic switching of vascular smooth muscle cells through the regulation of actin function and actin dependent gene expression. Cellular Signalling |
| Aubé A, Campbell S, Schmitzer AR, et al. (2017) Ultra-low fouling methylimidazolium modified surfaces for the detection of HER2 in breast cancer cell lysates. The Analyst |
| Bourmoum M, Claing A. (2017) The GTPase ARF6 Regulates Mitotic Exit and Cell Cycle Progression Journal of Pharmacological and Toxicological Methods. 88: 169 |
| Chingle R, Ratni S, Claing A, et al. (2016) Application of constrained aza-valine analogs for Smac mimicry. Biopolymers |
| Schlienger S, Campbell S, Pasquin S, et al. (2016) ADP-ribosylation factor 1 expression regulates epithelial-mesenchymal transition and predicts poor clinical outcome in triple-negative breast cancer. Oncotarget |
| Bourmoum M, Charles R, Claing A. (2016) The GTPase ARF6 Controls ROS Production to Mediate Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation. Plos One. 11: e0148097 |
| Charles R, Namkung Y, Cotton M, et al. (2015) βarrestin-Mediated Angiotensin II Signaling Controls the Activation of ARF6 and Endocytosis in Migration of Vascular Smooth Muscle Cells. The Journal of Biological Chemistry |
| Haines E, Schlienger S, Claing A. (2015) The small GTPase ADP-Ribosylation Factor 1 mediates the sensitivity of triple negative breast cancer cells to EGFR tyrosine kinase inhibitors. Cancer Biology & Therapy. 0 |